Search Results
Jul 08, 2026, 09:38 ET Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
for their therapeutic application.Scalable and Robust Processes: scalable from 2L to 50L bioreactors, enabling a seamless transition from R&D to commercial production.High Yield: final exosome product concentration ≥1E+11 particles/mLRapid Delivery: GMP-grade exosomes available
More news about: Porton Advanced
Jul 08, 2026, 09:37 ET Vermon launches Vermon Group, accelerating its growth and expanding its offerings
reduce complexity, and bring next-generation ultrasound technologies to market faster.With more than 600 employees worldwide, over 130 dedicated R&D experts, more than 40 years of ultrasound expertise, and manufacturing operations in Europe and the United States, Vermon Group continues to strengthen
More news about: VERMON SA
Jul 08, 2026, 09:21 ET Dzięki Hisense dom staje się najlepszym miejscem do oglądania Mistrzostw Świata FIFA 2026™
QINGDAO, Chiny, 8 lipca 2026 r. /PRNewswire/ -- Hisense, czołowa marka na światowym rynku elektroniki użytkowej i sprzętu AGD, na nowo definiuje sposób, w jaki kibice piłki nożnej przeżywają Mistrzostwa Świata FIFA 2026™
More news about: Hisense
Jul 08, 2026, 09:04 ET Neuspera Integrated Sacral Neuromodulation System (iSNM) to Receive Same Medicare Payment as Legacy Implantable SNM Devices Under Proposed 2027 CMS Rule
discomfort, and 18% report sleep or movement limitations. The Neuspera iSNM system was designed to completely eliminate these common issues.Dr. Charles R. Powell, Professor of Urology at Indiana University, commented: "Neuspera's externally powered iSNM system is a major step forward that I'm excited to
More news about: Neuspera Medical
Jul 08, 2026, 09:02 ET UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S.
Aleksander – Carmel Valley, CaliforniaBrady G. – Creston, WashingtonCameron T.Delaney N. – Tempe, ArizonaElisa R.Jodi D. – Seminole, FloridaLaura C. – Rockfield, KentuckyLily B.Michael Shaye V. – Fort Salonga, New YorkNaiya
More news about: UCB
Jul 08, 2026, 09:00 ET Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
for their therapeutic application.Scalable and Robust Processes: scalable from 2L to 50L bioreactors, enabling a seamless transition from R&D to commercial production.High Yield: final exosome product concentration ≥1E+11 particles/mLRapid Delivery: GMP-grade exosomes available
More news about: Porton Advanced
Jul 08, 2026, 09:00 ET UST Partners with Anthropic to Bring Claude into UST's Platforms, Engineering, and Operations and Train 20,000 UST Employees Globally
and led by our purpose, we partner with our clients from design to operation. Our AI-driven digital solutions, proprietary platforms, engineering, R&D, products, and innovation ecosystem turn core challenges into impactful, disruptive business outcomes. With deep industry knowledge and a future-ready
More news about: UST
Jul 08, 2026, 08:32 ET Where Deep Computer Science Meets Mainstream Culture: Kaon AI Closes Series B to Define Content Engine of the Generative AI Era
individualized narratives that truly resonate, moving the industry past static text prompts and into real-time multimedia."Scaling the San Mateo R&D Footprint for Personalized Content GenerationWith deep roots in the Bay Area research community and at its founders' alma mater, UC Berkeley,
More news about: Kaon AI
Jul 08, 2026, 08:30 ET Leprino Nutrition Challenges the Industry to Redefine Performance Protein at IFT FIRST 2026
portfolio."At our core, we work to understand our customers' products and formulations with the same level of detail and rigor as their own R&D teams," said B.T. Nauslar, vice president of sales and marketing at Leprino Nutrition. "Leprino Nutrition has the passion and dedication to invest
More news about: Leprino Nutrition
Jul 08, 2026, 08:23 ET Asana Partners i Norges Bank Investment Management nawiązują strategiczne przedsięwzięcie typu joint venture w sektorze lokalnego handlu detalicznego
Stanach ZjednoczonychCHARLOTTE, Karolina Północna, 8 lipca 2026 r. /PRNewswire/ -- Asana Partners poinformowała dziś o sfinalizowaniu partnerstwa z Norges Bank Investment Management („NBIM") w celu utworzenia
More news about: Asana Partners
Jul 08, 2026, 08:08 ET NFID Announces 2026-2027 Board of Directors
Immediate Past-President Jeffery A. Goad, PharmD, MPH; and Secretary-Treasurer Kevin M. Rooney. Oliver T. Brooks, MD, of Charles R. Drew University of Medicine and Science, and Flor M. Muñoz, MD, MSc, of Baylor College of Medicine, were reappointed for 3-year terms through
More news about: National Foundation for Infectious Diseases
Jul 08, 2026, 08:00 ET MSIG USA Appoints Three Independent Directors to Strengthen Board and Support Continued Growth
NEW YORK, July 8, 2026 /PRNewswire/ -- MSIG USA today announced the appointment of Darin Stafford, Thomas R. Sullivan, and Marc Gallo to the Board of Directors of MSIG Holdings (U.S.A.), Inc., further strengthening the company's governance and strategic leadership
More news about: MSIG USA
Jul 08, 2026, 08:00 ET Voiskey Officially Launches: The First AI Voice Typing App Focused on Expression Intelligence
5× increase in efficiency compared to traditional keyboard typing (validated by empirical data from 1,000 beta participants)."During product R&D and early beta testing, we observed that user expectations for voice interaction have shifted far beyond literal transcription accuracy. Today, professionals
More news about: Voiskey
Jul 08, 2026, 08:00 ET Acurx Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 14, 2026 Conference Call and Provide Business Update
Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin- resistant
More news about: Acurx Pharmaceuticals, Inc.
Jul 08, 2026, 07:46 ET SKF to publish Q2 report on 17 July
https://news.cision.com/skf/r/skf-to-publish-q2-report-on-17-july,c4372368The following files are available for download:
More news about: SKF
Jul 08, 2026, 07:40 ET SKF to publish Q2 report on 17 July
https://news.cision.com/skf/r/skf-to-publish-q2-report-on-17-july,c4372368The following files are available for download:
More news about: SKF
Jul 08, 2026, 07:30 ET BTQ Technologies Completes Acquisition of QPerfect, Advancing Its Mission of Building Trusted Quantum Technologies With World-Class Emulation, Digital Twin, and Control Capabilities
QPerfect in France, on the campus of the European Center for Quantum Sciences (CESQ)."QPerfect's Strasbourg Hub Anchors BTQ's European R&DThrough the Acquisition, BTQ will further anchor its European quantum research and development activities in Strasbourg, France, within a growing
More news about: BTQ Technologies Corp.
Jul 08, 2026, 06:30 ET Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
R&D Systems™ AI-Engineered Designer Protein portfolio, designed to improve reproducibility and performance across advanced cell culture and cell therapy development workflows.The R&D Systems AI-Engineered Designer Protein platform enables
More news about: Bio-Techne Corporation
Jul 08, 2026, 06:30 ET OneMain Holdings Announces Date of Second Quarter 2026 Earnings Release and Conference Call
www.OneMainFinancial.com.ContactsInvestor Contact:Peter R Poillon, [email protected]
More news about: OneMain Holdings, Inc.
Jul 08, 2026, 06:25 ET VinFast's Approach to Building Smarter Mobility
deployment. This system allows new technologies to mature under real-world driving conditions instead of controlled demonstrations alone.R&D Partnerships Powering the Next GenerationCentral to this roadmap is VinFast's expanding investment in research and development through
More news about: VinFast
Jul 08, 2026, 05:42 ET Yatsen Group Announces Partnership with Sephora China, Cementing Position as a Science-Led Beauty Innovation Leader
Since 2020, Yatsen has invested approximately $100 million (RMB 700 million) in R&D, establishing a robust global innovation ecosystem anchored by advanced research centers in China and Europe.This commitment to scientific innovation
More news about: Yatsen Holding Limited
Jul 08, 2026, 05:30 ET PROSUS N.V. ANNOUNCES CAPPED MAXIMUM AMOUNT FOR ITS PREVIOUSLY ANNOUNCED CAPPED TENDER OFFER
cash tender offer for its outstanding 3.257% Senior Notes due 2027 (Rule 144A CUSIP / ISIN: 74365P AG3 / US74365PAG37) (Regulation S CUSIP / ISIN: N7163R AW3 / USN7163RAW36) (the "Capped Tender Offer"), which is the aggregate principal amount of the New Senior Notes (as defined below) less U.S.$614,146,000.
More news about: Prosus N.V.
Jul 08, 2026, 05:15 ET Sectra publishes Annual Report and Sustainability Report for 2025/2026
https://news.cision.com/sectra/r/sectra-publishes-annual-report-and-sustainability-report-for-2025-2026,c4371898The following files are available for download:
More news about: Sectra
Jul 08, 2026, 05:11 ET Sectra publishes Annual Report and Sustainability Report for 2025/2026
https://news.cision.com/sectra/r/sectra-publishes-annual-report-and-sustainability-report-for-2025-2026,c4371898The following files are available for download:
More news about: Sectra
Jul 08, 2026, 05:03 ET Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy
review and meta-analysis. Eur J Epidemiol. 2020; 35(7):643-653. [Estimated mortality for those who receive ventilatory support.][4] Fischer R, et al. A Mixed-Method Study Exploring Patient-Experienced and Caregiver-Reported Benefits and Side Effects of Corticosteroid Use in Duchenne Muscular
More news about: Grünenthal Group